Company / Profit Margin
Kura Oncology, Inc. Profit Margin History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-413.0%
FY2025
5-year range
-413.0% / -322.9%
FY2024-FY2025
Trend
-27.9%
vs FY2024
Sector context
#119 of 146
Health Care
What the data says
Kura Oncology, Inc.'s profit margin of -413.0% is lower than 82% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
-413.0% in FY2025.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 146This company -413.0% Sector average -796.3%
▼
+48.1% above sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 27.9% year-over-year.
- Currently 383.3pp above the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -413.0% | -27.9% |
| FY2024 | -322.9% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026